Covington & Burling LLP has advised AbbVie, and Ropes & Gray LLP have advised Gilgamesh Pharmaceuticals.AbbVie has entered into a definitive agreement to acquire the lead…
AbbVie Acquires Gilgamesh’s Lead Antidepressant Program for Up to $1.2 Billion
